Skip to product information
1 of 1

NDA 208232 Orphan Drug Designation Letter for Mycapssa (6/17/10)

NDA 208232 Orphan Drug Designation Letter for Mycapssa (6/17/10)

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out

Contents: Orphan drug designation letter for Mycapssa (Octreotide), dated June 17, 2010.

New Drug Application (NDA): 208232
Company: CHIESI
Drug Name: MYCAPSSA
Active Ingredients: OCTREOTIDE ACETATE
Strength: EQ 20MG BASE
Dosage Form/Route: CAPSULE, DELAYED RELEASE;ORAL
Marketing Status:  Prescription

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome